|
| Press Releases |
|
 |
|
| Wednesday, November 30, 2022 |
|
|
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a constituent stock in the MSCI Global Micro Cap Index (Hong Kong), with such inclusion to become effective after the U.S. market close today. more info >> |
|
| Thursday, November 10, 2022 |
|
|
Prenetics 2022年第三季度财务业绩创纪录 上调2022年全年收入及经调整税息折旧及摊销前利润指引 |
| 全球领先的基因及诊断检测公司Prenetics Global Limited（纳斯达克：PRE）（“Prenetics” 或 “公司”）今日公布截至2022年9月30日止第三季度之未经审核财务业绩。 more info >> |
|
|
Prenetics 2022年第三季度財務業績創紀錄 上調2022年全年收入及經調整稅息折舊及攤銷前利潤指引 |
| 全球領先的基因及診斷檢測公司Prenetics Global Limited（納斯達克：PRE）（「Prenetics」或「公司」）今日公佈截至2022年9月30日止第三季度之未經審核財務業績。 more info >> |
|
|
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter ended September 30, 2022. more info >> |
|
| Friday, September 9, 2022 |
|
|
Prenetics公布2022年第二季度财务业绩 上调全年经调整税息折旧及摊销前利润预测 |
| 全球领先的基因及诊断检测公司Prenetics Global Limited（纳斯达克：PRE）（「Prenetics」或「公司」）今日公布其截止2022年6月30日的第二季度之未经审核财务业绩。 more info >> |
|
|
Prenetics公佈2022年第二季度財務業績 上調全年經調整稅息折舊及攤銷前利潤預測 |
| 全球領先的基因及診斷檢測公司Prenetics Global Limited（納斯達克：PRE）（「Prenetics」或「公司」）今日公佈其截止2022年6月30日的第二季度之未經審核財務業績。 more info >> |
|
|
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the second quarter ended June 30, 2022. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
MMG Announces 2025 Anuual Results, Record results, strong momentum
Mar 4, 2026 11:24 HKT/SGT
|
|
|
OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity
Mar 4, 2026 11:00 HKT/SGT
|
|
|
JCB, together with Resona, Realize a New Purchasing Experience: The World's First Full-Scale Project to Commercialize Ultra-Wideband (UWB) Payments
Mar 4, 2026 10:00 JST
|
|
|
OMP推出決策導向規劃方案 加速供應鏈決策速度
Mar 3, 2026 21:00 HKT/SGT
|
|
|
OMP推出决策导向型规划方案，加速供应链决策速度
Mar 3, 2026 21:00 HKT/SGT
|
|
|
TANAKA Establishes Transfer Technology for its Sintered Gold (Au) Bonding Technology "AuRoFUSE(TM) Preforms"
Mar 3, 2026 22:00 JST
|
|
|
五礦資源公佈2025年年度業績 業績創歷史新高 發展動能強勁
Mar 3, 2026 20:18 HKT/SGT
|
|
|
五矿资源公布2025年年度业绩 业绩创历史新高 发展动能强劲
Mar 3, 2026 20:18 HKT/SGT
|
|
|
Fujitsu and BCN Port Innovation Foundation leverage ocean digital twin technology to drive the regeneration of the Port of Barcelona
Mar 3, 2026 21:00 JST
|
|
|
MiniMax官宣向AI平台型公司邁進 ARR超1.5億美金夯實底盤
Mar 3, 2026 18:25 HKT/SGT
|
|
|
MiniMax官宣向AI平台型公司迈进 ARR超1.5亿美金夯实底盘
Mar 3, 2026 18:20 HKT/SGT
|
|
|
華領醫藥宣佈多格列艾汀在中國香港獲批上市
Mar 3, 2026 12:51 HKT/SGT
|
|
|
华领医药宣布多格列艾汀在中国香港获批上市
Mar 3, 2026 12:37 HKT/SGT
|
|
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Mar 3, 2026 12:14 HKT/SGT
|
|
|
愛康醫療(1789.HK)獲納入中證港股通機器人主題指數 凸顯機器人領域投資潛力
Mar 3, 2026 10:45 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
